← Home
Men's Health
Androgen axis, libido & performance
Common Stacks
1Men's Vitality Stack
Common PracticeRecomposition, recovery, and visceral fat reduction in men 35+.
- Protocol
- Tesamorelin 1–2 mg SQ nightly + Ipamorelin 200 mcg SQ AM fasted + BPC-157 250 mcg SQ as needed for joint/tendon load.
- Duration
- 12-week block, 4-week washout.
- Notes
- Monitor IGF-1 and fasting glucose at 6 and 12 weeks. Tesamorelin is Rx (HIV lipodystrophy indication).
16 peptides
Research UseGrade C
CJC-1295 (no DAC / Mod GRF 1-29)
Endocrine / GHRH Analog
Physiologic GH pulse amplification
Research UseGrade C
CJC-1295 (with DAC)
Endocrine / GHRH Analog
GH pulse amplificationIGF-1 elevation
Research UseGrade C
Follistatin 344
Regenerative / Myokine Modulator
Muscle growthAnti-fibrotic
Research UseGrade C
GHRP-2
Endocrine / GHRP
GH deficiency testingBody composition
Research UseGrade C
GHRP-6
Endocrine / GHRP
GH secretagogueAppetite stimulation
FDA ApprovedGrade B
Gonadorelin (GnRH)
Hormonal / GnRH Agonist
Hypogonadism diagnosticsHPTA maintenance
FDA ApprovedGrade A
hCG (Chorionic Gonadotropin)
Hormonal / Glycoprotein (not a true peptide)
Hypogonadotropic hypogonadismOvulation induction
Research UseGrade C
Hexarelin
Endocrine / GHRP-6 Analog
GH secretagogueCardioprotection (research)
Research UseGrade C
Ipamorelin
Endocrine / GHRP
GH secretagogueSleep optimization
Research UseGrade B
Kisspeptin-10
Reproductive / Hypothalamic Neuropeptide
HPG-axis stimulationHypothalamic amenorrhea (research)
Research UseGrade B
Kisspeptin-54
Hormonal / Kisspeptin
Reproductive axis stimulation (research)
FDA ApprovedGrade A
Leuprolide
Oncology / GnRH Agonist
Prostate CancerEndometriosis
Research UseGrade C
MK-677 (Ibutamoren)
Endocrine / GH Secretagogue
GH/IGF-1 elevationBody composition
Research UseGrade C
PT-141 (Research Grade)
Sexual Health / Melanocortin
Sexual dysfunction (men & women)Libido enhancement
FDA ApprovedGrade A
Sermorelin
Endocrine / GHRH Analog
Growth Hormone Deficiency (pediatric)
FDA ApprovedGrade A
Triptorelin
Hormonal / GnRH Agonist
Prostate cancerCentral precocious puberty